Bernard-Soulier Syndrome

Bernard-Soulier Syndrome is a rare inherited bleeding disorder that affects the blood's ability to clot properly. It involves a problem with the platelets, which are small cells that help stop bleeding by forming clots. People with this condition have fewer platelets and the platelets they do have are larger than normal, which makes it harder for blood to clot. This can lead to easy bruising, frequent nosebleeds, and prolonged bleeding after injuries or surgery. The disorder affects the body's blood clotting system and can cause significant bleeding problems throughout life. It is caused by a defect in a specific protein on the platelet surface that is important for sticking to blood vessel walls. Understanding this condition helps explain why bleeding is a major health concern for affected individuals.

Bernard-Soulier Syndrome is a rare autosomal recessive bleeding disorder characterized by a deficiency or dysfunction of the glycoprotein Ib-IX-V complex on platelet membranes. This complex is essential for platelet adhesion to the subendothelial von Willebrand factor during primary hemostasis. The core pathology involves defective platelet adhesion leading to macrothrombocytopenia (large platelets and low platelet count) and impaired clot formation. It is caused by mutations in genes such as GP1BA, GP1BB, or GP9 encoding components of the glycoprotein complex. Clinically, patients present with mucocutaneous bleeding, including epistaxis, menorrhagia, and easy bruising. Laboratory findings include prolonged bleeding time, thrombocytopenia with giant platelets on peripheral smear, and absent or reduced platelet agglutination in response to ristocetin. The disorder is significant due to its impact on hemostasis and risk of severe bleeding.